Literature DB >> 9389479

Nicotine activates and desensitizes midbrain dopamine neurons.

V I Pidoplichko1, M DeBiasi, J T Williams, J A Dani.   

Abstract

Tobacco use in developed countries is estimated to be the single largest cause of premature death. Nicotine is the primary component of tobacco that drives use, and like other addictive drugs, nicotine reinforces self-administration and place preference in animal studies. Midbrain dopamine neurons normally help to shape behaviour by reinforcing biologically rewarding events, but addictive drugs such as cocaine can inappropriately exert a reinforcing influence by acting upon the mesolimbic dopamine system. Here we show that the same concentration of nicotine achieved by smokers activates and desensitizes multiple nicotinic receptors thereby regulating the activity of mesolimbic dopamine neurons. Initial application of nicotine can increase the activity of the dopamine neurons, which could mediate the rewarding aspects of tobacco use. Prolonged exposure to even these low concentrations of nicotine, however, can cause desensitization of the nicotinic receptors, which helps to explain acute tolerance to nicotine's effects. The effects suggest a cellular basis for reports that the first cigarette of the day is the most pleasurable, whereas the effect of subsequent cigarettes may depend on the interplay between activation and desensitization of multiple nicotinic receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389479     DOI: 10.1038/37120

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  239 in total

Review 1.  The alpha7 nicotinic acetylcholine receptor in neuronal plasticity.

Authors:  R S Broide; F M Leslie
Journal:  Mol Neurobiol       Date:  1999-08       Impact factor: 5.590

2.  Ultrastructural localization of the alpha4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra.

Authors:  M M Arroyo-Jim nez; J P Bourgeois; L M Marubio; A M Le Sourd; O P Ottersen; E Rinvik; A Fairén; J P Changeux
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

Review 3.  Neurotransmitter release mechanisms in sympathetic neurons: past, present, and future perspectives.

Authors:  V M Jackson; T C Cunnane
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

4.  Cholinergic modulation of stellate cells in the mammalian ventral cochlear nucleus.

Authors:  K Fujino; D Oertel
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 5.  Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Authors:  Laura L Hurley; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-09-20       Impact factor: 3.911

Review 6.  Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.

Authors:  Ruthie E Wittenberg; Shannon L Wolfman; Mariella De Biasi; John A Dani
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

Review 7.  Pharmacotherapy for tobacco cessation: nicotine agonists, antagonists, and partial agonists.

Authors:  Maher Karam-Hage; Paul M Cinciripini
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

8.  Acquired appetitive responding to intravenous nicotine reflects a Pavlovian conditioned association.

Authors:  Jennifer E Murray; Rick A Bevins
Journal:  Behav Neurosci       Date:  2009-02       Impact factor: 1.912

9.  Functional polymorphisms in the human beta4 subunit of nicotinic acetylcholine receptors.

Authors:  Yong Liang; Ramiro Salas; Lisa Marubio; Dani Bercovich; Mariella De Biasi; Arthur L Beaudet; John A Dani
Journal:  Neurogenetics       Date:  2004-11-25       Impact factor: 2.660

Review 10.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.